Evidence map›Paper›PMID 36196583›Full record

ArticleESC heart failure2023

Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome.

Julio Núñez, Miguel Lorenzo, Gema Miñana, Patricia Palau, Jose V Monmeneu, Maria P López-Lereu, Jose Gavara, Víctor Marcos-Garcés, Cesar Rios-Navarro, Nerea Pérez and 6 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Julio NúñezCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Miguel LorenzoCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Gema MiñanaCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Patricia PalauCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Jose V MonmeneuCardiovascular Magnetic Resonance Unit, Exploraciones Radiológicas Especiales (ERESA), Valencia, Spain.
Maria P López-LereuCardiovascular Magnetic Resonance Unit, Exploraciones Radiológicas Especiales (ERESA), Valencia, Spain.
Jose GavaraInstituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
Víctor Marcos-GarcésCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Cesar Rios-NavarroInstituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
Nerea PérezInstituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
Elena de DiosInstituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
Eduardo NúñezCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Juan SanchisCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Francisco J ChorroCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Antoni Bayés-GenísCentro de Investigación Biomédica en Red - Cardiovascular (CIBER-CV), Madrid, Spain.
Vicent BodíCardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
INCLIVA Health Research Institute · ESCentro de Investigación Biomédica en Red · ESCentro de Investigación Biomédica en Red de Cáncer · ESEndesa (Spain) · ESHospital Clínico Universitario de Valencia · ESUniversitat de València · ESUniversitat Politècnica de València · ES

Funding

Agencia Estatal de Investigación FJC2020-043981-I/AEI/10.13039/501100011033Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina 16/11/00403Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina 16/11/00420Conselleria de Educación-Generalitat Valenciana PROMETEO/2021/008Fondos Europeos de Desarrollo Regional FEDER CIBERCV16/11/00420Fondos Europeos de Desarrollo Regional FEDER CIBERCV16/11/00486Instituto de Salud Carlos III CM21/00175Instituto de Salud Carlos III FI18/00320Instituto de Salud Carlos III PI20/00637Sociedad Española de Cardiología SEC/FEC-INV-CLI 21/024
6 · The paper itself

Abstract

aimsTraditional adverse events in chronic coronary syndrome (CCS) include atherothrombotic events but usually exclude heart failure (HF). Data are scarce about how new-onset HF modifies mortality risk. We aimed to determine the incidence of HF and compare its long-term mortality risk with myocardial infarction (MI) and stroke in patients with known or suspected CCS.

methodsWe prospectively evaluated 5811 consecutive HF-free patients submitted to vasodilator stress cardiac magnetic resonance (CMR) for known or suspected CCS. Ischaemic burden and left ventricular ejection fraction were assessed by CMR. HF included outpatient diagnosis or acute HF hospitalization. The mortality risk for the incident events and their cross-comparisons were evaluated using a Markov illness-death model with transition-specific survival models.

resultsThe mean age was 55 ± 11 years, and 38.9% were female. At a median follow-up of 5.44 (IQR = 2.53-8.55) years, 591 deaths were registered (1.79 per 100 P-Y). The rates of new-onset HF were higher compared with MI and stroke [1.02, 0.62, and 0.51, respectively (P < 0.05)]. The adjusted association between new-onset HF, MI, and stroke, and subsequent mortality was time dependent. The risk increased almost linearly for HF and became significant by the third year. By Year 10, the mortality risk attributable to new-onset HF was more than 2.5-fold (HR: 2.68, 95% CI = 1.74-4.12). For MI, there was a significant increase in mortality risk up to the second year, followed by a monotonic decrease. For stroke, the mortality risk increased for the entire follow-up but became significant by the third year. A cross-comparison among incident endpoints HF outnumbers risk for those with MI by the sixth year (HR

conclusionsIn patients with CCS, long-term rates of incident HF were higher than MI and stroke. Patients with new-onset HF showed a higher risk of long-term mortality.

Indexed as

Heart FailureMyocardial InfarctionStrokeAdultAgedFemaleHumansMaleMiddle AgedRisk FactorsStroke VolumeVentricular Function, LeftCardiac magnetic resonanceChronic coronary syndromeCoronary artery diseaseHeart failure

Identifiers

PMID36196583
PMCPMC9871680
OpenAlexW4302276203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.